Clinical Trial Update: Pegfilgrastim Versus Filgrastim After High-dose Chemotherapy [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing pegfilgrastim versus filgrastim for neutrophil recovery after high-dose chemotherapy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Malignancies
• Solid Tumors

Drugs mentioned

• Filgrastim (filgrastim)
• Pegfilgrastim (pegfilgrastim)

Snippet

Sponsor: Armando Santoro, MD | Conditions: Hematological Neoplasms, Tumors | Phase 2 | Status: COMPLETED